期刊文献+

血管紧张素转化酶2的研究进展 被引量:6

下载PDF
导出
摘要 肾素一血管紧张素系统(renin—angiotensin system,RAS)是一复杂的调节系统,在维持机体血压稳定和水电解质平衡中发挥了主导作用,RAS活性的增强与心血管病以及由这些疾病所致的脏器损害(如:心脏、血管、肾脏等)存在相关性。血管紧张素转化酶(ACE)是肾素一血管紧张素系统的重要调节酶,而血管紧张素转化酶2(angiotensinconverting enzyme2,ACE2)是近年新发现的与ACE具有较高同源性的酶,
作者 李小莉 温悦
出处 《中国药师》 CAS 2010年第4期569-572,共4页 China Pharmacist
  • 相关文献

参考文献25

  • 1Paul M,Poyan MA,Kreutz R.Physiology of local reninangiotensin systems[J].Physiol Rev,2006,86(3):747-803.
  • 2Burrell LM,Johnston CI,Tikellis C,et al.ACE2,a new regulator of the renninangiolensin system[J].Trends Endocrinol Metab,2004,15:166-169.
  • 3肖梅芳,周端.肾素-血管紧张素系统在心血管疾病进展中的作用[J].心血管病学进展,2005,26(2):137-140. 被引量:18
  • 4Tipnis SR,Hooper NM,Hyde R,et al.A human homologof angiotensin-converting enzyme.Cloning and functional expression as a captopril-insensitive carboxypeptidase[J].J BiolChem,2000,275(43):33238-33243.
  • 5孙琰,柳林,潘欣.SARS-CoV S666蛋白与眼部ACE2受体的结合作用[J].眼科新进展,2007,27(4):250-253. 被引量:4
  • 6Donoghue M,Hsieh F,Baronas E,et al.A novel angiotensin-converting enzymerelated carboxypeptidase(ACE2)converts angiotensin Ⅰ to angiotensin 1-9[J].Cirs Res,2000,87(5):E1-9.
  • 7Vicker C,Hales P,Kaushik V,et al.Hydrolysis of biollgical peptides by human angiotensin-converting enzyme-related carboxypeptidase[J].J Biol Chem,2002,277(17):14838-14843.
  • 8Huang LL,Sexton DJ,Skogerson K,et al.Novel peptide inhibitors of angiotensin-converting enzyme 2[J].J Biol Chem,2003,278(18):15532-15540.
  • 9Zisman LS,Keller RS,Weaver B,et al.Increased angiotensin-(1-7)-forming activity in failing human heartventricles:evidence forupregulation of the angiotensin-converting enzyme homologueACE2[J].Circulation,2003,108(14):1707-1712.
  • 10Gallagher PE,Ferrario CM,Tallant EA,et al.MAP kinase signaling regulates ACE2 expression[J].Hypertension,2004,44(4):513.

二级参考文献60

  • 1孙琰,柳林,潘欣.SARS冠状病毒S蛋白的功能性受体-ACE2[J].微生物学杂志,2004,24(4):25-30. 被引量:5
  • 2孙琰,潘欣,柳林,倪灿荣.SARS-CoVS蛋白功能性受体ACE2在人、兔角膜、结膜中的表达[J].眼科新进展,2004,24(5):332-336. 被引量:26
  • 3杨永健,张鑫,杨大春.血管紧张素1-7抑制血管外膜成纤维细胞增殖[J].中国动脉硬化杂志,2005,13(2):163-166. 被引量:4
  • 4Wolny A,Clozel JP,Rein J,et al.Functional and biochemical analysis of angiotensin Ⅱ-forming pathways in the human heart[J].Circ Res,1997,80(2):219-217.
  • 5de Gasparo M,Catt KJ,Inagami T,et al.International Union of Pharmacology.XXⅢ.The angiotensin Ⅱreceptor[J].Pharmacol Rev,2000,52:415-472.
  • 6Lucius R,Gallinat S,Busche S,et al.Beyond blood pressure:new roles for angiotensin Ⅱ[J].Cell Mol Life Sci,1999,56:1008-1019.
  • 7Stergiou GS,Skeva II.Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor:similarities and difference[J].Curr Top Med Chem,2004,4(4):473-481.
  • 8Unger T,Culman J,Gohike P.Angiotensin Ⅱ receptor blockade and end-organ protection:pharmacological rationale and evidence[J].J Hypertens,1996,14(suppl 7):s3-s9.
  • 9Nio Y,Matsubara H,Murasawa S,et al.Regulation of gene transcription of angiotensin Ⅱreceptor subtypes in myocardial infarction[J].J Clin Invest,1995,95:46-45.
  • 10Munzenmaier DH,Greene AS.Opposing actions of angiotensin Ⅱ on microvascular growth and arterial blood pressure[J].Hypertension,1996,27:760-765.

共引文献31

同被引文献43

  • 1陈健.抗高血压药物研究进展[J].天津医科大学学报,2004,10(S1):186-189. 被引量:10
  • 2万青松,谢红萍,欧继红.百令胶囊对早期2型糖尿病肾病的保护作用[J].中国药师,2009,12(2):225-226. 被引量:6
  • 3王梅.抗高血压药物的应用分析[J].现代中西医结合杂志,2004,13(17):2326-2326. 被引量:3
  • 4王道平,许玲.运动与血管紧张素Ⅱ[J].福建体育科技,2001,20(4):28-31. 被引量:1
  • 5田振军,王鹏,熊正英,夏家骝.过度负荷大鼠心脏左室心肌纤维及微血管变化的研究[J].体育与科学,1995,16(6):29-31. 被引量:13
  • 6Navarra-Gonzalez JF, Mora-Femandez C. The role of inflammatory cyto- kines in diabetic nephropathy [ J ]. J Am Soc Nephrol,2008 ,19 (3) :433.
  • 7Mogensen CE. Early diabetic renal involvement and nephropathy[ A ]. In : Alberti KGMM, Krall LP. The Diabetes Annual [ M ]. Vol 3. Am- sterdam: Elsevier Scinence Publishers, 1987. 306.
  • 8MiyAUChi K ,Takiyama Y, Honjyo J,et al. Upregulated IL-18 expres- sion in type 2 diabetic subjects with nephropathy: TGF-betal en- hanced IL-18 expression in human renal proximal tubular epithelia/ cells[ J ]. Diabetes Res Clin Pract , 2009 , 8 3 ( 2 ):190-199.
  • 9Fujita T, Ogihara N, Kamura Y, et al. Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications[ J]. Acta Diabetol,2010,18(6) : 121-125.
  • 10Araki S, HanedaM, Koya D ,et al. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes :an obser- vational follow up study[ J]. Diabetologia ,2007,50 (4) :867-873.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部